Irbesartan in patients with atrial fibrillation

The ACTIVE I Investigators (2011) Irbesartan in patients with atrial fibrillation. New England Journal of Medicine, 364 (10). pp. 928-938. ISSN 0028-4793

Full text not available from this repository.

Abstract

Irbesartan did not reduce cardiovascular events in patients with atrial fibrillation. (Funded by Bristol-Myers Squibb and Sanofi-Aventis; ClinicalTrials.gov number, NCT00249795.).

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023) Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Depositing User:	Rhiannon Harvey
Date Deposited:	29 Feb 2012 17:10
Last Modified:	26 Oct 2025 14:30
URI:	https://ueaeprints.uea.ac.uk/id/eprint/37735
DOI:	10.1056/NEJMoa1008816

Actions (login required)

View Item